PUMA BIOTECHNOLOGY, INC.: accounts_receivable
| Value | {"amount": 9670000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2017-12-31) |
| Status | current |
| Entity | PUMA BIOTECHNOLOGY, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T13:37:32.067047+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/4641c53d-9032-4ce1-9b7b-1c24b4d05da1
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-18-005152Retrieved: 2026-08-19T13:37:32.067047+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001401667/accounts-receivable/2017-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/4641c53d-9032-4ce1-9b7b-1c24b4d05da1
History
- no predecessors — first report